86 related articles for article (PubMed ID: 4199411)
1. Circulatory activity of a fully synthetic hydrogenated ergot alkaloid (DN 16-457).
Widmer LK; Hürlimann F; Radielovic P
Int J Clin Pharmacol; 1973 Aug; 8(1):5-10. PubMed ID: 4199411
[No Abstract] [Full Text] [Related]
2. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
Wanner J
Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016
[No Abstract] [Full Text] [Related]
3. [Therapy of pregnancy hypertension with Briserin].
Neubüser D
Munch Med Wochenschr; 1971 Apr; 113(18):697-702. PubMed ID: 4996491
[No Abstract] [Full Text] [Related]
4. [Alpha blocking properties of dihydro ergot derivatives. Findings on skin and muscle temperature].
D'Ayala Valva G; Dabizzi RP; Banchelli A
Riv Crit Clin Med; 1967 Aug; 67(3):191-9. PubMed ID: 4395433
[No Abstract] [Full Text] [Related]
5. Clinical experience with dihydroergocristine-reserpine-clopamide combination (brinerdin) in Ghanaian hypertensives.
Bandoh JK
Ghana Med J; 1973 Jun; 12(2):166-76. PubMed ID: 4218686
[No Abstract] [Full Text] [Related]
6. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)].
Pires de Oliveira RS
Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581
[No Abstract] [Full Text] [Related]
7. [Result of a clinical study with the hypotensive agent Briserin].
Frithz G
Ther Ggw; 1971 Aug; 110(8):1175-81. PubMed ID: 4999120
[No Abstract] [Full Text] [Related]
8. Vascular effects of dihydrogenated ergot alkaloids. Comparative effects of dihydroergostine and dihydroergotamine on the blood flow and the capacitance vessels in the human calf studied by plethysmography.
Ulrich J; Siggaard-Andersen J
Angiology; 1971 Dec; 22(11):622-8. PubMed ID: 5003295
[No Abstract] [Full Text] [Related]
9. [Clinical experience report on the combination antihypertensive agents DCR 1015 and DCR 515].
Obrowsky L; Kern H
Wien Med Wochenschr; 1969 Jan; 119(2):36-9. PubMed ID: 4976539
[No Abstract] [Full Text] [Related]
10. Leriche syndrome in a patient with prolonged and continuous use of ergot derivatives. A review of the vascular effects of ergot.
Pader E
Vasc Dis; 1967 Dec; 4(6):380-8. PubMed ID: 4965290
[No Abstract] [Full Text] [Related]
11. [Raubasine in combination with ergot alkaloid derivatives in the therapy of closed injuries of the brain].
Stoppani L
Arch Sci Med (Torino); 1965 Nov; 120(5):431-9. PubMed ID: 4956319
[No Abstract] [Full Text] [Related]
12. [Therapeutic experiences with the antihypertensive combination "Briserin"].
Nassehi AT
Med Klin; 1970 Oct; 65(43):1884-8. PubMed ID: 4990933
[No Abstract] [Full Text] [Related]
13. [Experimental study of the action of ergot hydrogenated derivates on neuroleptic-induced hypotension].
Van den Driessche J; Eben Moussi E; Allain P
Therapie; 1965; 20(3):655-68. PubMed ID: 4953938
[No Abstract] [Full Text] [Related]
14. An ergot alkaloid preparation (Hydergine) in the treatment of presenile brain atrophy (Alzheimer's disease): case report.
Burian E
J Am Geriatr Soc; 1974 Mar; 22(3):126-8. PubMed ID: 4204771
[No Abstract] [Full Text] [Related]
15. [Treatment of paresthetic nocturnal brachialgia with rexiluven].
Wolkerstorfer H
Munch Med Wochenschr; 1969 Feb; 111(9):503-5. PubMed ID: 4977172
[No Abstract] [Full Text] [Related]
16. [Effect of sympatholytics on the retinal vascular system].
Kozuchowska I; Chmurko E; Zawitkowski J
Klin Oczna; 1974 Jul; 44(7):661-6. PubMed ID: 4210840
[No Abstract] [Full Text] [Related]
17. [On the treatment of paresthesias in pregnancy with hydrogenated ergot alkaloids].
Grigolo B
Attual Ostet Ginecol; 1965; 11():Suppl:131-41. PubMed ID: 4957532
[No Abstract] [Full Text] [Related]
18. [Headaches in patients with vascular deficiency and their treatment with a raubasine-dihydroergocristine association].
Henry P
Bord Med; 1972 Nov; 5(18):2531-4. PubMed ID: 4196611
[No Abstract] [Full Text] [Related]
19. Letter: "Happy death day".
Cohen C
Br Med J; 1975 Dec; 4(5996):581. PubMed ID: 812583
[No Abstract] [Full Text] [Related]
20. Enhancement of the intestinal absorption of ergot peptide alkaloids in the rat by micellar solutions of polyoxyethylene-24-cholesteryl ether.
Franz JM; Vonderscher JP
J Pharm Pharmacol; 1981 Sep; 33(9):565-8. PubMed ID: 6117633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
